Finance

Lists
AMWL:NYSE
American Well Corp
$12.45
-3.79%
(-0.49) 1D
Aug 14, 4:00:08 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AMWL...
Open
$12.90
High
$13.22
Low
$12.42
Mkt. cap
211.76M
Avg. vol.
152.55K
Volume
57.25K
52-wk high
$14.19
52-wk low
$3.71
EPS
-$4.76
Beta
1.68
Shares outstanding
15.36M
No. of employees
562
Open
$12.90
High
$13.22
Low
$12.42
Mkt. cap
211.76M
Avg. vol.
152.55K
Volume
57.25K
52-wk high
$14.19
52-wk low
$3.71
EPS
-$4.76
Beta
1.68
Shares outstanding
15.36M
No. of employees
562
News stories
From web sources and news partners
Profile
American Well Corporation, doing business as Amwell, is a telemedicine company based in Boston, Massachusetts, that connects patients with doctors over secure video. Amwell sells its platform as a subscription service to healthcare providers to put their medical professionals online and its proprietary software development kits, APIs, and system integrations enable clients to embed telehealth into existing workflows utilized by providers and patients. Amwell has roughly 800 employees and has raised more than $500 million from investors, including Anthem, Philips, Allianz and Teva Pharmaceuticals, with the goal of connecting patients to healthcare providers remotely. The company operates in all 50 United States and works with 55 health plans, which support over 36,000 employers and collectively represent more than 80 million covered lives, as well as 240 of the nation's largest health systems, encompassing more than 2,000 hospitals. In 2020, over 40,000 providers were using the Amwell Platform. American Well was rebranded to Amwell on March 9, 2020. Wikipedia
About American Well Corp
CEOIdo Schoenberg
Employees562
FoundedJun 2006
HeadquartersBoston, Massachusetts, United States
SectorHealth care
Websitebusiness.amwell.com
Analyst ratings
Based on 7 analysts giving stock ratings to AMWL in the past 3 months
Hold
Buy
1
Hold
6
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AMWL in the last 3 months.
Highest
Current $12.45
$16.00 (+28.51%)
Average
$12.80 (+2.81%)
Lowest
$11.00 (-11.65%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jailendra Singh
Truist Financial
Hold
Reiterated
$12.00
-3.6%
08/13/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
$13.00
+4.4%
08/05/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
$16.00
+28.5%
08/05/2026
Stan Berenshteyn
Wells Fargo
Buy
Maintained
$16.00
+28.5%
08/05/2026
David Grossman
Stifel Nicolaus
Hold
Maintained
$11.00
-11.6%
08/05/2026
David Larsen
BTIG
Hold
Maintained
-
-
08/05/2026
Ryan MacDonald
Needham
Hold
Reiterated
-
-
08/05/2026
Charles Rhyee
TD Cowen
Hold
Reiterated
$12.00
-3.6%
08/05/2026
Last report
Aug 4, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.51 / -$0.60
+14.32%beat
Revenue / Est. (USD)
52.05M / 49.25M
+5.67%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
56.29M
55.31M
54.88M
52.05M
Cost of goods sold
26.78M
25.72M
25.75M
24.48M
Cost of revenue
26.78M
25.72M
25.75M
24.48M
Research and development expenses
18.58M
9.15M
10.96M
10.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.81M
25.89M
23.56M
20.45M
Operating expense
58.84M
43.53M
42.08M
37.77M
Total operating expenses
85.62M
69.26M
67.83M
62.25M
Operating income
-29.33M
-13.95M
-12.95M
-10.20M
Other non operating income
-
-
-
-617.00K
EBT including unusual items
-30.69M
-25.80M
-10.08M
-10.17M
EBT excluding unusual items
-28.69M
-14.51M
-12.63M
-10.82M
Income tax expense
1.22M
-626.00K
217.00K
-548.00K
Effective tax rate
-3.96%
2.43%
-2.15%
5.39%
Other operating expenses
-
-
-
-
Net income
-32.38M
-24.92M
-10.89M
-9.93M
Net profit margin
-57.52%
-45.06%
-19.83%
-19.07%
Earnings per share
-1.55
-1.12
-0.67
-0.51
Interest and investment income
638.00K
-
313.00K
-
Interest expense
-
-368.00K
-
-
Net interest expenses
638.00K
-368.00K
313.00K
-
Depreciation and amortization charges
9.44M
8.49M
7.56M
7.02M
EBITDA
-19.89M
-5.46M
-5.35M
-3.19M
Gain or loss from assets sale
2.00M
79.00K
-7.03M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps